Candesartan Cilexetil Tablets, 8 mg, 30-count bottle, Rx Only, Manufactured by Apotex Research Pv...

FDA Drug Recall #D-0242-2015 — Class III — October 16, 2014

Recall Summary

Recall Number D-0242-2015
Classification Class III — Low risk
Date Initiated October 16, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Apotex Inc.
Location Toronto, N/A
Product Type Drugs
Quantity 18,493

Product Description

Candesartan Cilexetil Tablets, 8 mg, 30-count bottle, Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326, NDC 60505-3619-3

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.

Distribution Pattern

Nationwide.

Lot / Code Information

Lot # KR3933; Exp.10/15 Lot # KR3935, KR3934; Exp.11/15

Other Recalls from Apotex Inc.

Recall # Classification Product Date
D-1303-2020 Class II Metformin Hydrochloride Extended-Release Tablet... May 27, 2020
D-0153-2020 Class III Atorvastatin Calcium Tablets, USP 40 mg*, 1,000... Oct 22, 2019
D-0316-2020 Class II Equate Maximum Strength Ranitidine Tablets, USP... Sep 24, 2019
D-0317-2020 Class II Rite Aid Pharmacy Maximum Strength Ranitidine T... Sep 24, 2019
D-0318-2020 Class II Equate Maximum Strength Ranitidine Tablets, USP... Sep 24, 2019

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.